%1

Coumarin is selected for consideration for listing by the Carcinogen Identification Committee and OEHHA is requesting for relevant information on the carcinogenic hazards of coumarin.

This is the comment period for the Proposed Rulemaking Notice, Title 27, Proposed Repeal of Sections 25607.30 and 25607.31.

-

OEHHA proposes to repeal Sections 25607.30 and 25607.31 to ensure consistency with the provisions of Section 25603.3, subsections (f) and (g) that reflect OEHHA’s intent concerning the BPA warning responsibility, methods and content provisions and an inoperative date of December 30, 2017.

Extension of the comment period on the proposal to adopt a No Significant Risk Level (NSRL) of 180 micrograms per day for malathion

-

OEHHA is issuing a safe use determination for DINP in Phifertex® fabric containing up to 25% DINP used in outdoor furniture products.

Reproductive Toxicity
Currently listed
Developmental Toxicity
Male Reproductive Toxicity
Female Reproductive Toxicity
Developmental Toxicity - Date of Listing
Developmental Toxicity - Listing Mechanism
Formally Required
Male Reproductive Toxicity - Date of Listing
Male Reproductive Toxicity - Listing Mechanism
Formally Required
Female Reproductive Toxicity - Date of Listing
Female Reproductive Toxicity - Listing Mechanism
Formally Required
Reproductive Toxicity
Currently listed
Developmental Toxicity
Developmental Toxicity - Date of Listing
Developmental Toxicity - Listing Mechanism
Formally Required

Pertuzumab and Vismodegib Listed Effective January 27, 2017 as Known to the State of California to Cause Reproductive Toxicity via the Formally Required to be Labeled or Identified (FR) mechanism.

Deadline to request a hearing on the proposal to adopt a No Significant Risk Level (NSRL) of 180 micrograms per day for malathion

-

Comment period on the proposal to adopt a No Significant Risk Level (NSRL) of 180 micrograms per day for malathion

-